MoonLake Immunotherapeutics (MLTX) Insider Trading

Name: MoonLake Immunotherapeutics (MLTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 29, 2026): Kristian Reich (Chief Scientific Officer): Sale of 1,100 shares, $22.0K.

Get alerted when insiders trade MLTX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta